The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
A re-post, but getting close to the 1 month mark since last sales figures.
Here is what sales figures COULD look like this week:
**Confirmed Sales**
27-Feb £0.9m
07-Mar £1.5m (+156%)
13-Mar £3.7m (+147%)
20-Mar £8.9m (+141%)
27-Mar £18m (+102%)
Then a few scenarios:
Scenario 1
**Potential Sales assuming growth rate decreases by 10% per week**
03-Apr £34.2m (+90%)
10-Apr £61.6m (+80%)
17-Apr £104.7m (+70%)
24-Apr £167.4m (+60%)
Scenario 2
**Potential Sales assuming growth rate decreases by 20% per week**
03-Apr £32.4m (+80%)
10-Apr £51.8m (+60%)
17-Apr £72.6m (+40%)
24-Apr £87.1m (+20%)
Scenario 3
**Potential Sales assuming sales continue at highest rate so far (£9m a week)**
03-Apr £27m (+£9m)
10-Apr £36m (+£9m)
17-Apr £45m (+£9m)
24-Apr £54m (+£9m)
Scenario 1 is maybe a little optimistic
Scenario 2 is IMO a good base for minimum figures.
Scenario 3 IMO is nowhere near the figure we will see.
REMEMBER all the amazing news of production increases, OEMs, distributors, approvals and so on we've had since the last recorded sales at 27th March.
Expecting £80m - £150m sales in next RNS.
Just if any of you missed my post yesterday:
Storage life of Genesig test at -20 degrees was previously 6 weeks, now increased to 18 months!
Again opens up massively for more orders. QiAmp by Qiagen is plastered on here too.
Technical Bulletin 101 - 09/04/2020
Accelerated Ageing Stability study and Real-Time Stability study update
The Accelerated Ageing Stability study is now complete and confirms that:
• The Assay can be shipped at ambient temperature
• The Assay is stable for at least 18 months when stored lyophilised at -20°C
• The Assay is stable for at least 6 months when resuspended and stored at -20°C
• The Assay is stable for up to 5 freeze/ thaw cycles
• The Real-Time Stability study is currently in progress.
https://www.genesig.com/assets/files/genesig_Real_Time_PCR_COVID_19_CE_IVD_Assay_Technical_Bulletin_101.pdf
Did anyone spot this?
Storage life of Genesig test at -20 degrees was previously 6 weeks, now increased to 18 months!
Again opens up massively for more orders. QiAmp by Qiagen is plastered on here too.
Technical Bulletin 101 - 09/04/2020
Accelerated Ageing Stability study and Real-Time Stability study update
The Accelerated Ageing Stability study is now complete and confirms that:
• The Assay can be shipped at ambient temperature
• The Assay is stable for at least 18 months when stored lyophilised at -20°C
• The Assay is stable for at least 6 months when resuspended and stored at -20°C
• The Assay is stable for up to 5 freeze/ thaw cycles
• The Real-Time Stability study is currently in progress.
https://www.genesig.com/assets/files/genesig_Real_Time_PCR_COVID_19_CE_IVD_Assay_Technical_Bulletin_101.pdf
https://privateharleystreetclinic.com/products/covid-19-test
The home test is already being sold.
https://privateharleystreetclinic.com/products/covid-19-test
There are still people saying £40m sales expected, or concerned of a lower than expected figure,
here is my post from earlier.
Here is what sales figures COULD look like:
**Confirmed Sales**
27-Feb £0.9m
07-Mar £1.5m +156%
13-Mar £3.7m +147%
20-Mar £8.9m +141%
27-Mar £18m +102%
Then a few scenarios:
**Potential Sales assuming growth rate decreases by 10% per week**
03-Apr £34.2m +90%
10-Apr £61.6m +80%
17-Apr £104.7m +70%
24-Apr £167.4m +60%
**Potential Sales assuming growth rate decreases by 20% per week**
03-Apr £32.4m +80%
10-Apr £51.8m +60%
17-Apr £72.6m +40%
24-Apr £87.1m +20%
**Potential Sales assuming sales continue at highest rate so far (£9m a week)**
03-Apr £27m +£9m
10-Apr £36m +£9m
17-Apr £45m +£9m
24-Apr £54m +£9m
Here are a few reasons why I think we will be seeing above £100m sales by next week:
1. Cost of test increase
2. Approvals: WHO, Saudi Arabia, India, Argentina and so on...
3. Sales now less limited by production, ramp up since to 4m tests/mo, then to 8m tests/mo
4. Increased severity of the pandemic
All IMO.
Just to break down what I think sales figures COULD look like if released this week.
**Confirmed Sales**
27-Feb £0.9m
**07-Mar** £1.5m +156%
13-Mar £3.7m +147%
20-Mar £8.9m +141%
27-Mar £18m +102%
Then a few scenarios:
**Potential Sales assuming growth rate decreases by 10% per week**
03-Apr £34.2m +90%
10-Apr £61.6m +80%
17-Apr £104.7m +70%
24-Apr £167.4m +60%
**Potential Sales assuming growth rate decreases by 20% per week**
03-Apr £32.4m +80%
10-Apr £51.8m +60%
17-Apr £72.6m +40%
24-Apr £87.1m +20%
**Potential Sales assuming sales continue at highest rate so far (£9m a week)**
03-Apr £27m +£9m
10-Apr £36m +£9m
17-Apr £45m +£9m
24-Apr £54m +£9m
Here are a few reasons why I think we will be seeing above £100m sales by next week:
1. Cost of test increase
2. Approvals: WHO, Saudi Arabia, India, Argentina and so on...
3. Sales now less limited by production, ramp up since to 4m tests/mo, then to 8m tests/mo
Plenty of other reasons to extract from recent RNS's.
All IMO.